Bryan Wahl Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity
Bryan Wahl is General Counsel of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 40,951 shares of TARS, which is worth approximately $2.25 Million. The most recent transaction as insider was on Mar 18, 2024, when has been sold 4,436 shares (Common Stock) at a price of $30.6 per share, resulting in proceeds of $135,741. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
41K
0%
3M change
28.11%
12M change
Total Value Held
$2.25 Million
Bryan Wahl Transaction History
BW
Bryan Wahl
General Counsel
Irvine, CA